Toru Yamada
Hokkaido University
7 Papers
2 Citations
Toru Yamada is an academic researcher from Hokkaido University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations.
Christopher P. Wardell,Masashi Fujita,Toru Yamada,Michele Simbolo,Matteo Fassan,Rosa Karlic,Paz Polak,Jaegil Kim,Yutaka Hatanaka,Kazuhiro Maejima,Rita T. Lawlor,Yoshitsugu Nakanishi,Tomoko Mitsuhashi,Akihiro Fujimoto,Mayuko Furuta,Andrea Ruzzenente,Simone Conci,Ayako Oosawa,Aya Sasaki-Oku,Kaoru Nakano,Hiroko Tanaka,Yujiro Yamamoto,Kubo Michiaki,Yoshiiku Kawakami,Hiroshi Aikata,Masaki Ueno,Shinya Hayami,Kunihito Gotoh,Shunichi Ariizumi,Masakazu Yamamoto,Hiroki Yamaue,Kazuaki Chayama,Satoru Miyano,Gad Getz,Aldo Scarpa,Satoshi Hirano,Toru Nakamura,Hidewaki Nakagawa +37 more
TL;DR: Large-scale genome sequencing analyses on biliary tract cancers suggest cell-of-origin predictions using WGS and epigenetic features suggest hepatocyte-origin of hepatitis-related ICCs, and these findings could be useful to establish treatment and diagnostic strategies for BTCs based on genetic information.
330
Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
Toru Yamada,Yoshitsugu Nakanishi,Keisuke Okamura,Takahiro Tsuchikawa,Toru Nakamura,Takehiro Noji,Toshimichi Asano,Kimitaka Tanaka,Yo Kurashima,Yuma Ebihara,Soichi Murakami,Toshiaki Shichinohe,Tomoko Mitsuhashi,Satoshi Hirano +13 more
TL;DR: The aim of this study was to measure the concentration of serum carbohydrate antigen 19‐9 (s‐CA19‐9) as a preoperative predictor of lymph node metastasis.
35
Metastatic mixed adenoneuroendocrine carcinoma of the liver successfully resected by hepatic trisectionectomy following chemotherapy: A case report.
Osamu Sato,Takahiro Tsuchikawa,Toru Yamada,Daisuke Sato,Yoshitsugu Nakanishi,Toshimichi Asano,Takehiro Noji,Kurashima Yo,Yuma Ebihara,Soichi Murakami,Toru Nakamura,Keisuke Okamura,Toshiaki Shichinohe,Tomoko Mitsuhashi,Satoshi Hirano +14 more
TL;DR: Chemotherapy for adenocarcinoma may be effective for MANEC, and resection after FOLFOX for unresectable metastatic MANEC of the liver is successfully performed.
7
CCR7 Mediates Cell Invasion and Migration in Extrahepatic Cholangiocarcinoma by Inducing Epithelial–Mesenchymal Transition
Mitsunobu Oba,Yoshitsugu Nakanishi,Tomoko Mitsuhashi,Katsunori Sasaki,Kanako C. Hatanaka,Masako Sasaki,Ayae Nange,Asami Okumura,Mariko Hayashi,Yusuke Yoshida,Takeo Nitta,Takashi Ueno,Toru Yamada,Masato Ono,Shota Kuwabara,Keisuke Okamura,Takahiro Tsuchikawa,Toru Nakamura,Takehiro Noji,Toshimichi Asano,Kimitaka Tanaka,Kiyoshi Takayama,Yutaka Hatanaka,Satoshi Hirano +23 more
TL;DR: In this paper , the prognostic impact of CCR7 expression and its association with clinicopathological features and EMT in EHCC was examined via the immunohistochemical staining of tumor sections from 181 patients with perihilar cholangiocarcinoma.
Postoperative Prognosis According to Pathologic Categorization of Desmoplastic Reaction in Patients with Extrahepatic Cholangiocarcinoma
Yu Yoshida,Yoshitsugu Nakanishi,Tomoko Mitsuhashi,Hiroyuki Yamamoto,Mariko Hayashi,Mitsunobu Oba,Takeo Nitta,Takashi Ueno,Toru Yamada,Masato Ono,Shota Kuwabara,Yutaka Hatanaka,Satoshi Hirano +12 more
TL;DR: In patients with EHCCs, DR categorization was an independent prognostic factor reflecting the distribution of tumor-promoting CAFs in the invasive front, and could stratify overall survival (OS) and relapse-free survival (RFS) in both PHCC and DCC patients.
4